Results 101 to 110 of about 65,190 (266)

Painful Bilateral Necrosis of the Scalp

open access: yes
JEADV Clinical Practice, EarlyView.
Zoé Dumesnil   +6 more
wiley   +1 more source

Axillary Lymph Node Yield Following Axillary Dissection in Biopsy‐Proven Node‐Positive Breast Cancer: Neoadjuvant Systemic Therapy Versus Primary Surgery

open access: yesANZ Journal of Surgery, EarlyView.
ABSTRACT Background Neoadjuvant systemic therapy (NAST) induces morphological changes within the axilla; however, its impact on lymph node yield (LNY) following axillary lymph node dissection (ALND) is less clear. Methods A retrospective cohort study was performed including female patients who underwent ALND for biopsy‐proven node‐positive breast ...
Zachary Pluim   +4 more
wiley   +1 more source

Breast Angiosarcoma: 15‐Years Experience

open access: yesANZ Journal of Surgery, EarlyView.
ABSTRACT Background Breast angiosarcoma is a rare, aggressive malignancy that can be primary (PAS) or secondary (SAS). This study evaluates the management and outcomes of breast angiosarcoma in a single‐center breast/surgical oncology unit. Methods A retrospective review was conducted on patients with histologically confirmed PAS or SAS who underwent ...
Gaik Si Quah   +2 more
wiley   +1 more source

Breast Skin Necrosis After Methylene Blue Dye İnjection: Breast İmage

open access: yesSakarya Tıp Dergisi, 2018
Sentinel lymph node dissection is the gold standard treatment for non-lymph node metastatic breast cancers. Here we present, a 41-year-old woman with a BIRADS-5 mass in the left retroareolar area.
Arda Işık   +5 more
doaj   +1 more source

Sentinel Lymph Node Biopsy in Clinically Node‐Negative Merkel Cell Carcinoma: An Update of the Westmead Hospital Experience

open access: yesANZ Journal of Surgery, EarlyView.
ABSTRACT Background Merkel cell carcinoma (MCC) is a rare, aggressive cutaneous neuroendocrine malignancy with a high risk of nodal metastasis. Sentinel lymph node biopsy (SLNB) is used to stage clinically node‐negative disease and to guide adjuvant therapy decisions.
Julie Ahn   +2 more
wiley   +1 more source

Evaluation of diagnostic value of sentinel lymph node biopsy in breast cancer

open access: yesمجله دانشگاه علوم پزشکی گرگان, 2013
Background and Objective: Dissection of the axillary lymph nodes is considered as one of the common measures in management of breast cancer. Edema and limitation in hand movement are accompanied with dissection of axillary lymph nodes.
Abdollahi M   +7 more
doaj  

Infection control in the brain and the eye

open access: yesActa Ophthalmologica, EarlyView.
Abstract The Central Nervous System (CNS), comprising the brain and the eye, is considered to have a ‘privileged’ mechanism for dealing with immunological challenge (immune privilege, IP). CNS IP has been revealed through experiments using foreign protein antigens and cell and tissue alloantigens (grafts), but evidence for a role for IP in modulating ...
John V. Forrester   +2 more
wiley   +1 more source

The Accuracy of Sentinel Lymph Node Biopsy Compared with Axillary Lymph Node Dissection in Breast Cancer

open access: yesMiddle East Journal of Cancer, 2011
Background: Sentinel lymph node biopsy is used as an accurate staging procedure to detect early breast cancer. Several studies have documented that sentinel lymph node biopsy can accurately determine the status of axillary nodes.
Abdolrasul Talei   +3 more
doaj  

Sentinel Lymph Node Biopsy Following Neoadjuvant Chemotherapy: Review of the Literature and Recommendations for Use in Patient Management

open access: yesAsian Journal of Surgery, 2004
Breast cancer is a significant health problem worldwide and is one of the leading causes of cancer-related mortality in women. Preoperative chemotherapy has become the standard of care for patients with locally advanced disease and is being used more ...
Yan Xing   +3 more
doaj   +1 more source

The Australian Penile Cancer Clinical Registry: a comprehensive national approach to data collection

open access: yesBJU International, EarlyView.
Background Penile cancer is a rare malignancy, with an Australian incidence of 0.6 in 100 000 men, with a wide range of clinical presentations, from localised, curable tumours to aggressive forms with high morbidity and mortality. Epidemiological data and management guidelines for penile cancer in Australia are limited.
Henry Y.C. Pan   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy